Relation Therapeutics

Relation Therapeutics is a techbio drug-discovery company that combines single-cell multi-omics from patient tissue, functional lab assays and machine learning in a 'Lab-in-the-Loop' platform to map disease biology and identify novel drug targets. It uses these maps to discover and develop medicines, with an initial focus on osteoporosis and other areas of high unmet need. Based in London, the company raised a $35M seed extension in March 2024 led by DCVC and co-led by NVIDIA's venture arm NVentures, bringing total seed funding to about $60M. Additional investors include Khosla Ventures, ARK Invest, Deerfield Management and Magnetic Ventures.